Cambridge Investment Research Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59K | Hold |
|
|||||
|
2025
Q1 | $64K | Hold |
|
|||||
|
2024
Q4 | $104K | Hold |
|
|||||
|
2024
Q3 | $48K | Hold |
|
|||||
|
2024
Q2 | $46K | Hold |
|
|||||
|
2024
Q1 | $52K | Hold |
|
|||||
|
2023
Q4 | $44K | Buy |
|
|||||
|
2023
Q3 | $105K | Hold |
|
|||||
|
2023
Q2 | $159K | Hold |
|
|||||
|
2023
Q1 | $124K | Hold |
|
|||||
|
2022
Q4 | $242K | Sell |
|
|||||
|
2022
Q3 | $245K | Buy |
|
|||||
|
2022
Q2 | $214K | Hold |
|
|||||
|
2022
Q1 | $264K | Hold |
|
|||||
|
2021
Q4 | $223K | Hold |
|
|||||
|
2021
Q3 | $276K | Buy |
|
|||||
|
2021
Q2 | $258K | Hold |
|
|||||
|
2021
Q1 | $370K | Sell |
|
|||||
|
2020
Q4 | $290K | Buy |
|
|||||
|
2020
Q3 | $115K | Hold |
|
|||||
|
2020
Q2 | $72K | Hold |
|
|||||
|
2020
Q1 | $46K | Hold |
|
|||||
|
2019
Q4 | $84K | Hold |
|
|||||
|
2019
Q3 | $48K | Buy |
|